Loading clinical trials...
Loading clinical trials...
Vectors Post Market: A Study to Assess Pain Relief Using Spinal Cord Stimulation (SCS) With High Dose (HD) Stimulation Parameters
This is a prospective, single-arm, multi-center study evaluating the efficacy of spinal cord stimulation (SCS) therapy for pain relief using high dose (HD) stimulation parameters delivered to neural targets identified during current commercial trial stimulation procedures. The study will evaluate changes in back and leg pain from baseline to 3, 6, and 12 months.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Pain Consultants of San Diego
La Mesa, California, United States
Restore Orthopedics and Spine Center
Orange, California, United States
Center for Interventional Pain and Spine
Wilmington, Delaware, United States
Pain Care
Stockbridge, Georgia, United States
National Spine and Pain
Oxon Hill, Maryland, United States
Michigan Pain Consultants
Wyoming, Michigan, United States
Comprehensive and Interventional Pain Management
Henderson, Nevada, United States
The Pain Management Center
Voorhees Township, New Jersey, United States
University of Rochester Neurosurgery Partners Pain Management
Rochester, New York, United States
Carolinas Pain Center
Huntersville, North Carolina, United States
Start Date
November 30, 2017
Primary Completion Date
February 4, 2019
Completion Date
October 21, 2019
Last Updated
November 3, 2020
175
ACTUAL participants
Spinal Cord Stimulation System
DEVICE
Lead Sponsor
MedtronicNeuro
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06219408